Latest news
10 questions on Germany
Bruno Cavalier
Chief Economist at ODDO BHF
Germany today took over the six-month presidency of the Council of the EU with ambitions that would not have been thought possible even a short while ago. End-2019, it recorded the weakest growth rate in the EU, apart from Italy. It was suffering from trade frictions and the slump in the automotive sector. Deficits were banned, the ECB was held responsible for expropriating savers, European integration was not being widely lauded. Angela Merkel was criticised within her own party. Six months later, the situation has completely changed. The economy is devastated, but less so than elsewhere, and the Chancellor is once again the central figure in domestic and European affairs.
Germany takes the helm of the EU
The EU has a half-yearly rotating presidency in order to involve each member state, be they large or small, in the organisation of its affairs, but let’s be honest and concede that people are rarely interested in the name of the country hosting the presidency. As a coincidence of the calendar, Germany, the biggest EU country, will occupy this position in exceptional circumstances. First, the EU has just experienced the greatest shock in its history. Second, with the UK’s exit, the EU is losing one of its biggest member states and future relations between the two entities will have to be clarified between now and the end of the year. In the present note, we examine Germany’s own situation and its relations with other EU member-states. For the sake of clarity, we have divided our presentation into ten questions.
- What is the (provisional) assessment of the pandemic?
At the time of writing, the pandemic has been clearly receding in all EU countries in recent weeks. This is a general relief, but the human toll varies from country to country. According to the excess mortality, Germany looks like one of the countries that has "managed" the epidemic most effectively1. A broad-based testing campaign was implemented as of March, which helped to rapidly circumscribe the main centres of the outbreak of the virus. This policy has been made possible in part through private sector initiative, often in a decentralised manner. At the same time, in France, the government was clumsily trying to justify its lack of preparation (shortage of masks). Germany adopted lockdown measures, but these were less severe than in other countries and were therefore able to be lifted more rapidly (chart lhs). A few more or fewer days of lockdown are important for the measurement of growth in Q2, and thus for 2020.
1 According to analysis by the FT (https://www.ft.com/coronavirusfree), the excess mortality rate during the coronavirus crisis was 6% in Germany, vs 24% in France, 25% in the US, 26% in Sweden, 43% in Italy, 49% in the UK and 56% in Spain.
Disclaimer:
This publication is produced by ODDO BHF Corporates & Markets, a division of ODDO BHF SCA (“ODDO”), which is licensed by the Autorité de Contrôle Prudentiel et de Résolution (ACPR) and regulated by the Autorité des Marchés Financiers (“AMF”).
This document, when distributed outside of the U.S., is intended exclusively for non-U.S. customers of ODDO and cannot be divulged to a third-party without prior written consent of ODDO. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. This document has been developed by our economists. It does not constitute a financial analysis and has not been developed in accordance with legal requirements designed to promote the independence of investment research. Accordingly, there are no prohibitions on personal dealing ahead of its dissemination. “Chinese walls” (information barriers) have been implemented to avert the unauthorized dissemination of confidential information and to prevent and manage situations of conflict of interest.
At the time of publication of this document, ODDO and/or one of its subsidiaries may have a conflict of interest with the issuer(s) mentioned. While all reasonable effort has been made to ensure that the information contained is not untrue or misleading at the time of publication, no representation is made as to its accuracy or completeness and it should not be relied upon as such. Past performances offer no guarantee as to future performances. All opinions expressed in the present document reflect the current context which is subject to change without notice. The statements, assumptions and forecasts contained in this document reflect the judgment of its author(s), unless otherwise specified, and do not reflect the judgment of any other person or of ODDO. This document does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation in this document is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice.
This document is for institutional investors only. It may not contain information necessary for others to make investment decisions. Consult your financial adviser or an investment professional if you are not an institutional investor.
Disclaimers for Distribution by ODDO BHF New York Corporation to United States Investors:
Please refer to the most recent research reports on the subject companies for complete information and relevant disclosures.
This document is produced by ODDO BHF Corporates & Markets, a division of ODDO BHF SCA ( “ODDO”). It is distributed to U.S. investors exclusively by ODDO BHF New York Corporation (“ONY”), MEMBER: FINRA/SIPC, and is intended exclusively for U.S. institutional customers of ONY and cannot be divulged to a third-party without prior written consent of ONY. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. This document is being furnished to you for informational purposes only and should not be relied upon as sufficient to form a basis for any investment decision.
At the time of publication of this document, ODDO, and/or one of its subsidiaries may have investment banking and other business relationships with any of the companies in this report. While all reasonable effort has been made to ensure that the information contained is not untrue or misleading at the time of publication, no representation is made as to its accuracy or completeness and it should not be relied upon as such. However, ODDO has no obligation to update or amend any information contained in this publication. Past performance offers no guarantee as to future performance. All opinions expressed in the present document reflect the current context which is subject to change without notice. This document does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of particular clients. Clients should consider whether any advice or recommendation in this document is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice.
This document is not a research report as defined in FINRA Rule 2241(a)(11) because the material in it is limited to one or more of the exclusions of the definition of research report in Rule 2241(a)(11)(A). This document is for institutional investors only. Consult your financial adviser or an investment professional if you are not sure you are an institutional investor.
Disclosures Required by United States Laws and Regulations:
Rule 15a-6 Disclosure: Under Rule 15a-6(a), any transactions conducted by ODDO, and/or one of its subsidiaries with U.S. persons in the securities described in this document must be effected through ONY.
Contact Information of firm distributing investment recommendations to U.S. investors: ODDO BHF New York Corporation, MEMBER: FINRA/SIPC, is a wholly owned subsidiary of ODDO BHF SCA; Philippe Bouclainville, President ([email protected]) 150 East 52nd Street New York, NY 10022 212-481-4002.
Statement of conflict of interests of all companies mentioned in this document may be consulted on Oddo & Cie’s research site .